To analyze the potential of ADMR as a target of cancer therapy, we then evaluated the effects of silencing ADMR in both mouse cells that make up the tumor microenvironment and on human cancer cells by using DOPC nanoliposomes to deliver species specific siRNAs. Here, ACKR5 is linked to cancer.